AlphAIalphai — Financial news for AI agents
AD HOC NEWSAPR 304 min read$COO

The Cooper Companies Stock (US21664P1039): Q1 2026 Earnings Set for Release Today

The Cooper Companies (US21664P1039) is poised to release its first-quarter 2026 financial results today, April 30. Investors will be scrutinizing the performance of its contact lenses (CooperVision) and women's health (CooperSurgical) segments for insights into growth, margins, and supply chain resilience. The company operates globally, with a strong presence in the U.S., and is known for its research-driven product development and strategic acquisitions in specialty healthcare.

Original reporting
AD HOC NEWS · AD HOC NEWS Editorial Team
Published Apr 30, 2026, 9:59 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Apr 30, 2026, 10:22 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
The Cooper Companies Stock (US21664P1039): Q1 2026 Earnings Set for Release Today — source image
Source · AD HOC NEWS
Decision brief

The 30-second read

$COONeutralMed
01

Why it matters

Earnings are expected to shed light on operational resilience amid supply chain challenges and competitive pressures.

02

Market read

The earnings release is a key event for healthcare investors, with potential to influence sector sentiment and stock valuations.

03

What to watch

Supply chain disruptions or macroeconomic factors not reflected in current sentiment could influence outcomes.

Timing: Immediate, as earnings are released today.

Background

The Cooper Companies operates in contact lenses (CooperVision) and women's health (CooperSurgical), with a strong U.S. presence and a history of strategic acquisitions.

Company-level read

Ticker impact

$COONeutralMedium confidence
Context

The upcoming Q1 2026 earnings release for The Cooper Companies is highly relevant for investors interested in healthcare and specialty medical devices sectors.

Expected impact

Potential for moderate positive movement if results exceed expectations; risk of decline if results disappoint.

Evidence & confidence

The relevance of the earnings release is high, but actual market reaction depends on the reported results relative to expectations.

Market effects

Sector

Positive outlook for the healthcare devices and women's health sectors, contingent on strong earnings.

Regional

Primarily U.S.-focused, with potential ripple effects in global healthcare markets.

Global

Limited, unless results significantly differ from forecasts, prompting broader market adjustments.

Counterpoint

What could challenge this read

Disappointing earnings could lead to short-term declines, presenting buying opportunities for long-term investors.

Key entities

  • Company
    The Cooper Companies

    A global healthcare company specializing in medical devices and surgical products.

  • Segment
    CooperVision

    The company's contact lens division.

  • Segment
    CooperSurgical

    The company's women's health division.

Read at source← All news

Related articles

JUN 5
$COOMedAI 8/10

Natixis Advisors LLC Buys 270,476 Shares of The Cooper Companies, Inc. $COO

Natixis Advisors LLC increased its stake in The Cooper Companies by buying 270,476 shares in Q4, bringing holdings to 303,456 shares, according to its latest SEC 13F. The position was valued at about $24.9M (~0.15%). Separately, the article notes Cooper’s fiscal Q2 EPS of $1.21 (vs $1.10 consensus) and revenue of $1.08B, plus FY2026 EPS guidance of $4.58–$4.66.

dailypolitical.com6 min
JUN 3
$COOMedAI 9/10

CooperCompanies (COO) Reports Q1: Everything You Need To Know Ahead Of Earnings

CooperCompanies (COO) is set to report Q1 earnings Thursday after the bell. The company reported Q1 revenue of $1.02B, up 6.2% year over year, and met revenue expectations; it beat full-year EPS guidance, with organic revenue in line. For Q1, analysts expect 5.1% revenue growth. CooperCompanies shares are down 3.3% over a month; the average analyst price target is $88.21 vs. $59.50.

finance.yahoo.com5 min
AUG 25
$RTXMedAI 8/10

The winners in China's missile leap

RTX and Lockheed Martin are key players in the U.S. missile production buildup, with RTX winning a $22.9B Navy deal and Lockheed holding a $58.6B Patriot agreement. Both companies have multi-year contracts. Analysts see 9.26% upside for RTX and 12.20% for Lockheed. Production capacity is a key risk.

yahoo.com2 min
AUG 25
$NVDALow

Jensen Huang Said Nvidia's $30 Billion OpenAI Investment Might Be the Last. Nvidia Just Guaranteed Up to $105 Billion of OpenAI's Leases.

Nvidia's CEO, Jensen Huang, stated that a $30B investment in OpenAI might be the last, as OpenAI plans to go public. Nvidia later committed to backing up to $105B of OpenAI's data center leases. The guarantees are contingent on OpenAI's insolvency or lease defaults, with reimbursement agreements in place. Nvidia's Q1 revenue was $81.6B, up 85% YoY, with Q2 guidance at $91B.

fool.com2 min